InMed Pharmaceuticals, Inc. (INM)

1.36 +0.03 (+2.26%) USD  |  NASDAQ  |  Oct 09, 16:00
1.37 +0.01 (+0.74%) After-Hours: 20:00
More

InMed Pharmaceuticals Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for INM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2022. Start Trial.
Date Value
February 16, 2024 --
January 17, 2024 --
November 16, 2023 --
Date Value
October 02, 2023 --
July 20, 2023 --
February 15, 2022 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) --

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade